Inflammation and CV risk: Beyond statins in the treatment of atherosclerosis

Media formats available:

Ongoing benefit with bempedoic acid in reducing total incidence of MACE
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
ESC Congress 2023
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
- Stephen Nicholls, MD
Lessons from a trial with colchicine in patients undergoing thoracic surgery
Lessons from a trial with colchicine in patients undergoing thoracic surgery
ESC Congress 2023
Lessons from a trial with colchicine in patients undergoing thoracic surgery
- Lukas Hoes, MD
- David Conen, MD
Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
ESC Congress 2023
Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
- David Conen, MD
A publication on CV risk in autoimmune diseases
A publication on CV risk in autoimmune diseases
EAS 2023
A publication on CV risk in autoimmune diseases
- Jeanine Roeters van Lennep, MD, PhD
- Pierre Sabouret, MD, PhD

PACE-CME